According to this study, over the next five years the Cancer Biomarker market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cancer Biomarker business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Biomarker market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Cancer Biomarker, covering the supply chain analysis, impact assessment to the Cancer Biomarker market size growth rate in several scenarios, and the measures to be undertaken by Cancer Biomarker companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- Protein Biomarker
- Genetic Biomarker
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
- Diagnostics
- Research
- Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- Thermo Fisher Scientific
- Abbott Laboratories
- Bio-Rad Laboratories
- Qiagen
- Illumina
- Roche Diagnostics
- Biomérieux SA
- GE Healthcare
- Merck & Co.
- Agilent Technologies
- Quest Diagnostics
- Becton, Dickinson and Company
- Sysmex Corporation
- Myriad Genetics
- Hologic
- Danaher Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
- To study and analyze the global Cancer Biomarker consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Cancer Biomarker market by identifying its various subsegments.
- Focuses on the key global Cancer Biomarker manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Cancer Biomarker with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Cancer Biomarker submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global Cancer Biomarker Market Growth 2020-2025
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Biomarker Consumption 2015-2025
2.1.2 Cancer Biomarker Consumption CAGR by Region
2.2 Cancer Biomarker Segment by Type
2.2.1 Protein Biomarker
2.2.2 Genetic Biomarker
2.3 Cancer Biomarker Consumption by Type
2.3.1 Global Cancer Biomarker Consumption Market Share by Type (2015-2020)
2.3.2 Global Cancer Biomarker Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cancer Biomarker Sale Price by Type (2015-2020)
2.4 Cancer Biomarker Segment by Application
2.4.1 Diagnostics
2.4.2 Research
2.4.3 Others
2.5 Cancer Biomarker Consumption by Application
2.5.1 Global Cancer Biomarker Consumption Market Share by Type (2015-2020)
2.5.2 Global Cancer Biomarker Value and Market Share by Type (2015-2020)
2.5.3 Global Cancer Biomarker Sale Price by Type (2015-2020)
3 Global Cancer Biomarker by Company
3.1 Global Cancer Biomarker Sales Market Share by Company
3.1.1 Global Cancer Biomarker Sales by Company (2018-2020)
3.1.2 Global Cancer Biomarker Sales Market Share by Company (2018-2020)
3.2 Global Cancer Biomarker Revenue Market Share by Company
3.2.1 Global Cancer Biomarker Revenue by Company (2018-2020)
3.2.2 Global Cancer Biomarker Revenue Market Share by Company (2018-2020)
3.3 Global Cancer Biomarker Sale Price by Company
3.4 Global Cancer Biomarker Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cancer Biomarker Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cancer Biomarker Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cancer Biomarker by Regions
4.1 Cancer Biomarker by Regions
4.2 Americas Cancer Biomarker Consumption Growth
4.3 APAC Cancer Biomarker Consumption Growth
4.4 Europe Cancer Biomarker Consumption Growth
4.5 Middle East & Africa Cancer Biomarker Consumption Growth
5 Americas
5.1 Americas Cancer Biomarker Consumption by Countries
5.1.1 Americas Cancer Biomarker Consumption by Countries (2015-2020)
5.1.2 Americas Cancer Biomarker Value by Countries (2015-2020)
5.2 Americas Cancer Biomarker Consumption by Type
5.3 Americas Cancer Biomarker Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cancer Biomarker Consumption by Regions
6.1.1 APAC Cancer Biomarker Consumption by Regions (2015-2020)
6.1.2 APAC Cancer Biomarker Value by Regions (2015-2020)
6.2 APAC Cancer Biomarker Consumption by Type
6.3 APAC Cancer Biomarker Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cancer Biomarker by Countries
7.1.1 Europe Cancer Biomarker Consumption by Countries (2015-2020)
7.1.2 Europe Cancer Biomarker Value by Countries (2015-2020)
7.2 Europe Cancer Biomarker Consumption by Type
7.3 Europe Cancer Biomarker Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cancer Biomarker by Countries
8.1.1 Middle East & Africa Cancer Biomarker Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cancer Biomarker Value by Countries (2015-2020)
8.2 Middle East & Africa Cancer Biomarker Consumption by Type
8.3 Middle East & Africa Cancer Biomarker Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cancer Biomarker Distributors
10.3 Cancer Biomarker Customer
11 Global Cancer Biomarker Market Forecast
11.1 Global Cancer Biomarker Consumption Forecast (2021-2025)
11.2 Global Cancer Biomarker Forecast by Regions
11.2.1 Global Cancer Biomarker Forecast by Regions (2021-2025)
11.2.2 Global Cancer Biomarker Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cancer Biomarker Forecast by Type
11.8 Global Cancer Biomarker Forecast by Application
12 Key Players Analysis
12.1 Thermo Fisher Scientific
12.1.1 Company Information
12.1.2 Cancer Biomarker Product Offered
12.1.3 Thermo Fisher Scientific Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Thermo Fisher Scientific Latest Developments
12.2 Abbott Laboratories
12.2.1 Company Information
12.2.2 Cancer Biomarker Product Offered
12.2.3 Abbott Laboratories Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Abbott Laboratories Latest Developments
12.3 Bio-Rad Laboratories
12.3.1 Company Information
12.3.2 Cancer Biomarker Product Offered
12.3.3 Bio-Rad Laboratories Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Bio-Rad Laboratories Latest Developments
12.4 Qiagen
12.4.1 Company Information
12.4.2 Cancer Biomarker Product Offered
12.4.3 Qiagen Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Qiagen Latest Developments
12.5 Illumina
12.5.1 Company Information
12.5.2 Cancer Biomarker Product Offered
12.5.3 Illumina Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Illumina Latest Developments
12.6 Roche Diagnostics
12.6.1 Company Information
12.6.2 Cancer Biomarker Product Offered
12.6.3 Roche Diagnostics Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Roche Diagnostics Latest Developments
12.7 Biomérieux SA
12.7.1 Company Information
12.7.2 Cancer Biomarker Product Offered
12.7.3 Biomérieux SA Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Biomérieux SA Latest Developments
12.8 GE Healthcare
12.8.1 Company Information
12.8.2 Cancer Biomarker Product Offered
12.8.3 GE Healthcare Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 GE Healthcare Latest Developments
12.9 Merck & Co.
12.9.1 Company Information
12.9.2 Cancer Biomarker Product Offered
12.9.3 Merck & Co. Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Merck & Co. Latest Developments
12.10 Agilent Technologies
12.10.1 Company Information
12.10.2 Cancer Biomarker Product Offered
12.10.3 Agilent Technologies Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Agilent Technologies Latest Developments
12.11 Quest Diagnostics
12.11.1 Company Information
12.11.2 Cancer Biomarker Product Offered
12.11.3 Quest Diagnostics Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Quest Diagnostics Latest Developments
12.12 Becton, Dickinson and Company
12.12.1 Company Information
12.12.2 Cancer Biomarker Product Offered
12.12.3 Becton, Dickinson and Company Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Becton, Dickinson and Company Latest Developments
12.13 Sysmex Corporation
12.13.1 Company Information
12.13.2 Cancer Biomarker Product Offered
12.13.3 Sysmex Corporation Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Sysmex Corporation Latest Developments
12.14 Myriad Genetics
12.14.1 Company Information
12.14.2 Cancer Biomarker Product Offered
12.14.3 Myriad Genetics Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Myriad Genetics Latest Developments
12.15 Hologic
12.15.1 Company Information
12.15.2 Cancer Biomarker Product Offered
12.15.3 Hologic Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Hologic Latest Developments
12.16 Danaher Corporation
12.16.1 Company Information
12.16.2 Cancer Biomarker Product Offered
12.16.3 Danaher Corporation Cancer Biomarker Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Danaher Corporation Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Cancer Biomarker Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Protein Biomarker
Table 5. Major Players of Genetic Biomarker
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Cancer Biomarker Consumption Market Share by Type (2015-2020)
Table 8. Global Cancer Biomarker Revenue by Type (2015-2020) ($ million)
Table 9. Global Cancer Biomarker Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Cancer Biomarker Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Cancer Biomarker Consumption Market Share by Application (2015-2020)
Table 13. Global Cancer Biomarker Value by Application (2015-2020)
Table 14. Global Cancer Biomarker Value Market Share by Application (2015-2020)
Table 15. Global Cancer Biomarker Sale Price by Application (2015-2020)
Table 16. Global Cancer Biomarker Sales by Company (2017-2019) (K Units)
Table 17. Global Cancer Biomarker Sales Market Share by Company (2017-2019)
Table 18. Global Cancer Biomarker Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Cancer Biomarker Revenue Market Share by Company (2017-2019)
Table 20. Global Cancer Biomarker Sale Price by Company (2017-2019)
Table 21. Global Cancer Biomarker Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Cancer Biomarker Products Offered
Table 23. Cancer Biomarker Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Cancer Biomarker Consumption by Regions 2015-2020 (K Units)
Table 25. Global Cancer Biomarker Consumption Market Share by Regions 2015-2020
Table 26. Global Cancer Biomarker Value by Regions 2015-2020 ($ Millions)
Table 27. Global Cancer Biomarker Value Market Share by Regions 2015-2020
Table 28. Americas Cancer Biomarker Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Cancer Biomarker Consumption Market Share by Countries (2015-2020)
Table 30. Americas Cancer Biomarker Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Cancer Biomarker Value Market Share by Countries (2015-2020)
Table 32. Americas Cancer Biomarker Consumption by Type (2015-2020) (K Units)
Table 33. Americas Cancer Biomarker Consumption Market Share by Type (2015-2020)
Table 34. Americas Cancer Biomarker Consumption by Application (2015-2020) (K Units)
Table 35. Americas Cancer Biomarker Consumption Market Share by Application (2015-2020)
Table 36. APAC Cancer Biomarker Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Cancer Biomarker Consumption Market Share by Regions (2015-2020)
Table 38. APAC Cancer Biomarker Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Cancer Biomarker Value Market Share by Regions (2015-2020)
Table 40. APAC Cancer Biomarker Consumption by Type (2015-2020) (K Units)
Table 41. APAC Cancer Biomarker Consumption Market Share by Type (2015-2020)
Table 42. APAC Cancer Biomarker Consumption by Application (2015-2020) (K Units)
Table 43. APAC Cancer Biomarker Consumption Market Share by Application (2015-2020)
Table 44. Europe Cancer Biomarker Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Cancer Biomarker Consumption Market Share by Countries (2015-2020)
Table 46. Europe Cancer Biomarker Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Cancer Biomarker Value Market Share by Countries (2015-2020)
Table 48. Europe Cancer Biomarker Consumption by Type (2015-2020) (K Units)
Table 49. Europe Cancer Biomarker Consumption Market Share by Type (2015-2020)
Table 50. Europe Cancer Biomarker Consumption by Application (2015-2020) (K Units)
Table 51. Europe Cancer Biomarker Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Cancer Biomarker Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Cancer Biomarker Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Cancer Biomarker Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Cancer Biomarker Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Cancer Biomarker Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Cancer Biomarker Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Cancer Biomarker Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Cancer Biomarker Consumption Market Share by Application (2015-2020)
Table 60. Cancer Biomarker Distributors List
Table 61. Cancer Biomarker Customer List
Table 62. Global Cancer Biomarker Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Cancer Biomarker Consumption Market Forecast by Regions
Table 64. Global Cancer Biomarker Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Cancer Biomarker Value Market Share Forecast by Regions
Table 66. Global Cancer Biomarker Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Cancer Biomarker Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Cancer Biomarker Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Cancer Biomarker Value Market Share Forecast by Type (2021-2025)
Table 70. Global Cancer Biomarker Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Cancer Biomarker Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Cancer Biomarker Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Cancer Biomarker Value Market Share Forecast by Application (2021-2025)
Table 74. Thermo Fisher Scientific Product Offered
Table 75. Thermo Fisher Scientific Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Thermo Fisher Scientific Main Business
Table 77. Thermo Fisher Scientific Latest Developments
Table 78. Thermo Fisher Scientific Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Laboratories Product Offered
Table 80. Abbott Laboratories Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Abbott Laboratories Main Business
Table 82. Abbott Laboratories Latest Developments
Table 83. Abbott Laboratories Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 84. Bio-Rad Laboratories Product Offered
Table 85. Bio-Rad Laboratories Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Bio-Rad Laboratories Main Business
Table 87. Bio-Rad Laboratories Latest Developments
Table 88. Bio-Rad Laboratories Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 89. Qiagen Product Offered
Table 90. Qiagen Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Qiagen Main Business
Table 92. Qiagen Latest Developments
Table 93. Qiagen Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 94. Illumina Product Offered
Table 95. Illumina Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Illumina Main Business
Table 97. Illumina Latest Developments
Table 98. Illumina Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 99. Roche Diagnostics Product Offered
Table 100. Roche Diagnostics Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Roche Diagnostics Main Business
Table 102. Roche Diagnostics Latest Developments
Table 103. Roche Diagnostics Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 104. Biomérieux SA Product Offered
Table 105. Biomérieux SA Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 106. Biomérieux SA Main Business
Table 107. Biomérieux SA Latest Developments
Table 108. Biomérieux SA Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. GE Healthcare Product Offered
Table 110. GE Healthcare Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. GE Healthcare Main Business
Table 112. GE Healthcare Latest Developments
Table 113. GE Healthcare Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck & Co. Product Offered
Table 115. Merck & Co. Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Merck & Co. Main Business
Table 117. Merck & Co. Latest Developments
Table 118. Merck & Co. Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 119. Agilent Technologies Product Offered
Table 120. Agilent Technologies Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. Agilent Technologies Main Business
Table 122. Agilent Technologies Latest Developments
Table 123. Agilent Technologies Basic Information, Company Total Revenue (in $ million), Cancer Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 124. Quest Diagnostics Product Offered
Table 125. Quest Diagnostics Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. Quest Diagnostics Main Business
Table 127. Quest Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Quest Diagnostics Latest Developments
Table 129. Becton, Dickinson and Company Product Offered
Table 130. Becton, Dickinson and Company Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Becton, Dickinson and Company Main Business
Table 132. Becton, Dickinson and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Becton, Dickinson and Company Latest Developments
Table 134. Sysmex Corporation Product Offered
Table 135. Sysmex Corporation Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Sysmex Corporation Main Business
Table 137. Sysmex Corporation Latest Developments
Table 138. Sysmex Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Myriad Genetics Product Offered
Table 140. Myriad Genetics Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 141. Myriad Genetics Main Business
Table 142. Myriad Genetics Latest Developments
Table 143. Myriad Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Hologic Product Offered
Table 145. Hologic Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 146. Hologic Main Business
Table 147. Hologic Latest Developments
Table 148. Hologic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Danaher Corporation Product Offered
Table 150. Danaher Corporation Cancer Biomarker Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 151. Danaher Corporation Main Business
Table 152. Danaher Corporation Latest Developments
Table 153. Danaher Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Cancer Biomarker
Figure 2. Cancer Biomarker Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cancer Biomarker Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Cancer Biomarker Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Protein Biomarker
Figure 7. Product Picture of Genetic Biomarker
Figure 8. Global Cancer Biomarker Consumption Market Share by Type (2015-2020)
Figure 9. Global Cancer Biomarker Value Market Share by Type (2015-2020)
Figure 10. Cancer Biomarker Consumed in Diagnostics
Figure 11. Global Cancer Biomarker Market: Diagnostics (2015-2020) (K Units)
Figure 12. Global Cancer Biomarker Market: Diagnostics (2015-2020) ($ Millions)
Figure 13. Cancer Biomarker Consumed in Research
Figure 14. Global Cancer Biomarker Market: Research (2015-2020) (K Units)
Figure 15. Global Cancer Biomarker Market: Research (2015-2020) ($ Millions)
Figure 16. Cancer Biomarker Consumed in Others
Figure 17. Global Cancer Biomarker Market: Others (2015-2020) (K Units)
Figure 18. Global Cancer Biomarker Market: Others (2015-2020) ($ Millions)
Figure 19. Global Cancer Biomarker Consumption Market Share by Application (2015-2020)
Figure 20. Global Cancer Biomarker Value Market Share by Application (2015-2020)
Figure 21. Global Cancer Biomarker Sales Market Share by Company in 2017
Figure 22. Global Cancer Biomarker Sales Market Share by Company in 2019
Figure 23. Global Cancer Biomarker Revenue Market Share by Company in 2017
Figure 24. Global Cancer Biomarker Revenue Market Share by Company in 2019
Figure 25. Global Cancer Biomarker Sale Price by Company in 2019
Figure 26. Global Cancer Biomarker Consumption Market Share by Regions 2015-2020
Figure 27. Global Cancer Biomarker Value Market Share by Regions 2015-2020
Figure 28. Americas Cancer Biomarker Consumption 2015-2020 (K Units)
Figure 29. Americas Cancer Biomarker Value 2015-2020 ($ Millions)
Figure 30. APAC Cancer Biomarker Consumption 2015-2020 (K Units)
Figure 31. APAC Cancer Biomarker Value 2015-2020 ($ Millions)
Figure 32. Europe Cancer Biomarker Consumption 2015-2020 (K Units)
Figure 33. Europe Cancer Biomarker Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Cancer Biomarker Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Cancer Biomarker Value 2015-2020 ($ Millions)
Figure 36. Americas Cancer Biomarker Consumption Market Share by Countries in 2019
Figure 37. Americas Cancer Biomarker Value Market Share by Countries in 2019
Figure 38. Americas Cancer Biomarker Consumption Market Share by Type in 2019
Figure 39. Americas Cancer Biomarker Consumption Market Share by Application in 2019
Figure 40. United States Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 41. United States Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Cancer Biomarker Consumption Market Share by Countries in 2019
Figure 47. APAC Cancer Biomarker Value Market Share by Regions in 2019
Figure 48. APAC Cancer Biomarker Consumption Market Share by Type in 2019
Figure 49. APAC Cancer Biomarker Consumption Market Share by Application in 2019
Figure 50. China Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 51. China Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 58. India Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 59. India Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Cancer Biomarker Consumption Market Share by Countries in 2019
Figure 63. Europe Cancer Biomarker Value Market Share by Countries in 2019
Figure 64. Europe Cancer Biomarker Consumption Market Share by Type in 2019
Figure 65. Europe Cancer Biomarker Consumption Market Share by Application in 2019
Figure 66. Germany Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 68. France Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 69. France Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 70. UK Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 71. UK Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Cancer Biomarker Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Cancer Biomarker Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Cancer Biomarker Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Cancer Biomarker Consumption Market Share by Application in 2019
Figure 80. Egypt Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Cancer Biomarker Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Cancer Biomarker Value Growth 2015-2020 ($ Millions)
Figure 90. Global Cancer Biomarker Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Cancer Biomarker Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 93. Americas Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 94. APAC Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 95. APAC Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 96. Europe Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 97. Europe Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 100. United States Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 101. United States Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 102. Canada Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 103. Canada Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 104. Mexico Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 105. Mexico Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 106. Brazil Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 107. Brazil Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 108. China Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 109. China Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 110. Japan Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 111. Japan Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 112. Korea Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 113. Korea Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 116. India Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 117. India Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 118. Australia Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 119. Australia Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 120. Germany Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 121. Germany Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 122. France Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 123. France Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 124. UK Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 125. UK Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 126. Italy Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 127. Italy Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 128. Russia Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 129. Russia Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 130. Spain Cancer Biomarker Consumption 2021-2025 (K Units)
Figure 131. Spain Cancer Biomarker Value 2021-2025 ($ Millions)
Figure 132.
Global Biomarkers Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period.
The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 114
Market Overview of Global Biomarker (Medicine) market:
According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years.
Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 131
According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Commercializing Biom......
Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Dec-2023 Price: US 3380 Onwards Pages: 100
Market Overview of Global Biomarkers market:
According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......
Global Biomarker Technology Market Research Report 2023
Published: 01-Dec-2023 Price: US 2900 Onwards Pages: 86
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Laboratories
- Quanterix
- Bio-Rad Laboratories
- Epigenomics
- Agilent Technologies
- Johnson & Johnson
- Qiagen
- Roche Ho......
Global Renal Biomarkers Market Research Report 2023
Published: 01-Dec-2023 Price: US 2900 Onwards Pages: 99
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Diagnostics
- F. Hoffmann-La Roche
- Beckman Coulter
- Siemens Healthcare Diagnostics
- Thermo Fisher Scientific
- Astute Medical
- Bio......
Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 114
Market Overview of Global Central Nervous System (CNS) Biomarkers market:
According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
An overview of the global market for central nervous system (CNS) biomarke......
Global Cancer Biomarker Market Research Report 2023
Published: 13-Nov-2023 Price: US 2900 Onwards Pages: 109
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Roche Diagnostics
- Qiagen
- Illumina
- GE Healthcare
- Agilent Technologies
- Biomér......
Biomarker Collaboration and Licensing Deals 2016-2023
Published: 01-Nov-2023 Price: US 3995 Onwards Pages: 300
Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023.
The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs